O	0	9	Hepatitis	Hepatitis	NN	B-NP
O	10	11	B	B	NN	I-NP
O	12	17	virus	virus	NN	I-NP
O	18	29	integration	integration	NN	I-NP
O	30	35	event	event	NN	I-NP
O	36	38	in	in	IN	B-PP
O	39	44	human	human	JJ	B-NP
B-Cellular_component	45	55	chromosome	chromosome	NN	I-NP
I-Cellular_component	56	59	17p	17p	NN	I-NP
O	60	64	near	near	IN	B-PP
O	65	68	the	the	DT	B-NP
O	69	72	p53	p53	NN	I-NP
O	73	77	gene	gene	NN	I-NP
O	78	88	identifies	identify	VBZ	B-VP
O	89	92	the	the	DT	B-NP
O	93	99	region	region	NN	I-NP
O	100	102	of	of	IN	B-PP
O	103	106	the	the	DT	B-NP
B-Cellular_component	107	117	chromosome	chromosome	NN	I-NP
O	118	126	commonly	commonly	RB	B-VP
O	127	134	deleted	delete	VBN	I-VP
O	135	137	in	in	IN	B-PP
B-Cancer	138	143	virus	virus	NN	B-NP
I-Cancer	143	144	-	-	HYPH	B-NP
I-Cancer	144	152	positive	positive	JJ	I-NP
I-Cancer	153	167	hepatocellular	hepatocellular	JJ	I-NP
I-Cancer	168	178	carcinomas	carcinoma	NNS	I-NP
O	178	179	.	.	.	O

O	181	184	The	The	DT	B-NP
O	185	196	development	development	NN	I-NP
O	197	199	of	of	IN	B-PP
B-Cancer	200	214	hepatocellular	hepatocellular	JJ	B-NP
I-Cancer	215	224	carcinoma	carcinoma	NN	I-NP
O	225	226	(	(	(	O
B-Cancer	226	229	HCC	HCC	NN	B-NP
O	229	230	)	)	)	O
O	231	241	presumably	presumably	RB	B-ADVP
O	242	248	occurs	occur	VBZ	B-VP
O	249	251	in	in	IN	B-PP
O	252	260	multiple	multiple	JJ	B-NP
O	261	266	steps	step	NNS	I-NP
O	267	270	and	and	CC	O
O	271	273	is	be	VBZ	B-VP
O	274	284	influenced	influence	VBN	I-VP
O	285	287	by	by	IN	B-PP
O	288	296	numerous	numerous	JJ	B-NP
O	297	304	factors	factor	NNS	I-NP
O	304	305	.	.	.	O

O	306	315	Hepatitis	Hepatitis	NN	B-NP
O	316	317	B	B	NN	I-NP
O	318	323	virus	virus	NN	I-NP
O	324	325	(	(	(	O
O	325	328	HBV	HBV	NN	B-NP
O	328	329	)	)	)	O
O	330	332	is	be	VBZ	B-VP
O	333	341	strongly	strongly	RB	I-VP
O	342	352	associated	associate	VBN	I-VP
O	353	357	with	with	IN	B-PP
O	358	361	the	the	DT	B-NP
O	362	373	development	development	NN	I-NP
O	374	376	of	of	IN	B-PP
B-Cancer	377	380	HCC	HCC	NN	B-NP
O	381	383	in	in	IN	B-PP
O	384	390	people	people	NNS	B-NP
O	391	402	chronically	chronically	RB	B-VP
O	403	411	infected	infect	VBN	I-VP
O	412	416	with	with	IN	B-PP
O	417	420	the	the	DT	B-NP
O	421	426	virus	virus	NN	I-NP
O	426	427	,	,	,	O
O	428	431	but	but	CC	O
O	432	435	the	the	DT	B-NP
O	436	445	mechanism	mechanism	NN	I-NP
O	446	448	of	of	IN	B-PP
O	449	454	viral	viral	JJ	B-NP
O	455	466	involvement	involvement	NN	I-NP
O	467	474	remains	remain	VBZ	B-VP
O	475	482	unclear	unclear	JJ	B-ADJP
O	482	483	.	.	.	O

O	484	487	One	One	CD	B-NP
O	488	499	possibility	possibility	NN	I-NP
O	500	502	is	be	VBZ	B-VP
O	503	507	that	that	IN	B-SBAR
O	508	511	the	the	DT	B-NP
O	512	517	gross	gross	JJ	I-NP
B-Cellular_component	518	529	chromosomal	chromosomal	JJ	I-NP
O	530	541	alterations	alteration	NNS	I-NP
O	542	552	frequently	frequently	RB	B-VP
O	553	561	observed	observe	VBN	I-VP
O	562	564	in	in	IN	B-PP
B-Cancer	565	568	HCC	HCC	NN	B-NP
O	569	572	DNA	DNA	NN	I-NP
O	573	575	at	at	IN	B-PP
O	576	579	the	the	DT	B-NP
O	580	584	site	site	NN	I-NP
O	585	587	of	of	IN	B-PP
O	588	591	HBV	HBV	NN	B-NP
O	592	603	integration	integration	NN	I-NP
O	604	607	may	may	MD	B-VP
O	608	613	alter	alter	VB	I-VP
O	614	617	the	the	DT	B-NP
O	618	628	expression	expression	NN	I-NP
O	629	631	of	of	IN	B-PP
O	632	641	important	important	JJ	B-NP
O	642	648	nearby	nearby	JJ	I-NP
B-Cell	649	657	cellular	cellular	JJ	I-NP
O	658	663	genes	gene	NNS	I-NP
O	663	664	.	.	.	O

O	665	667	We	We	PRP	B-NP
O	668	678	previously	previously	RB	B-ADVP
O	679	687	reported	report	VBD	B-VP
O	688	691	the	the	DT	B-NP
O	692	699	cloning	cloning	NN	I-NP
O	700	703	and	and	CC	I-NP
O	704	720	characterization	characterization	NN	I-NP
O	721	723	of	of	IN	B-PP
O	724	725	a	a	DT	B-NP
O	726	729	HBV	HBV	NN	I-NP
O	730	736	insert	insert	NN	I-NP
O	737	741	from	from	IN	B-PP
O	742	743	a	a	DT	B-NP
O	744	751	Chinese	Chinese	JJ	I-NP
B-Cancer	752	755	HCC	HCC	NN	I-NP
O	755	756	.	.	.	O

O	757	760	The	The	DT	B-NP
O	761	766	viral	viral	JJ	I-NP
O	767	773	insert	insert	NN	I-NP
O	774	780	mapped	map	VBN	B-VP
O	781	783	to	to	TO	B-PP
B-Cellular_component	784	794	chromosome	chromosome	NN	B-NP
I-Cellular_component	795	800	17p11	17p11	CD	I-NP
I-Cellular_component	800	801	.	.	.	O
I-Cellular_component	801	802	2	2	CD	B-NP
I-Cellular_component	802	803	-	-	HYPH	I-NP
I-Cellular_component	803	805	12	12	CD	I-NP
O	805	806	,	,	,	O
O	807	810	and	and	CC	O
B-Cell	811	819	cellular	cellular	JJ	B-NP
O	820	829	sequences	sequence	NNS	I-NP
O	830	834	were	be	VBD	B-VP
O	835	845	duplicated	duplicate	VBN	I-VP
O	846	848	at	at	IN	B-PP
O	849	852	the	the	DT	B-NP
O	853	857	site	site	NN	I-NP
O	858	860	of	of	IN	B-PP
O	861	866	viral	viral	JJ	B-NP
O	867	878	integration	integration	NN	I-NP
O	878	879	.	.	.	O

O	880	882	In	In	IN	B-PP
O	883	886	the	the	DT	B-NP
O	887	894	present	present	JJ	I-NP
O	895	900	study	study	NN	I-NP
O	901	902	a	a	DT	B-NP
O	903	906	DNA	DNA	NN	I-NP
O	907	912	probe	probe	NN	I-NP
O	913	920	derived	derive	VBN	B-VP
O	921	925	from	from	IN	B-PP
B-Cell	926	934	cellular	cellular	JJ	B-NP
O	935	938	DNA	DNA	NN	I-NP
O	939	948	sequences	sequence	NNS	I-NP
O	949	957	adjacent	adjacent	JJ	B-ADJP
O	958	960	to	to	TO	B-PP
O	961	964	the	the	DT	B-NP
O	965	975	previously	previously	RB	I-NP
O	976	989	characterized	characterize	VBN	I-NP
O	990	993	HBV	HBV	NN	I-NP
O	994	1000	insert	insert	NN	I-NP
O	1001	1004	was	be	VBD	B-VP
O	1005	1009	used	use	VBN	I-VP
O	1010	1012	to	to	TO	B-VP
O	1013	1020	analyze	analyze	VB	I-VP
O	1021	1022	a	a	DT	B-NP
O	1023	1026	set	set	NN	I-NP
O	1027	1029	of	of	IN	B-PP
O	1030	1032	19	19	CD	B-NP
O	1033	1040	matched	match	VBD	B-VP
O	1041	1047	normal	normal	JJ	B-NP
B-Organ	1048	1053	liver	liver	NN	I-NP
O	1054	1057	and	and	CC	I-NP
O	1058	1061	HBV	HBV	NN	I-NP
O	1061	1062	-	-	HYPH	B-NP
O	1062	1070	positive	positive	JJ	I-NP
B-Tissue	1071	1079	hepatoma	hepatoma	NN	I-NP
I-Tissue	1080	1087	samples	sample	NNS	I-NP
O	1088	1096	obtained	obtain	VBN	B-VP
O	1097	1101	from	from	IN	B-PP
O	1102	1105	the	the	DT	B-NP
O	1106	1110	same	same	JJ	I-NP
O	1111	1117	region	region	NN	I-NP
O	1118	1120	of	of	IN	B-PP
O	1121	1126	China	China	NNP	B-NP
O	1126	1127	,	,	,	O
O	1128	1132	near	near	IN	B-PP
O	1133	1141	Shanghai	Shanghai	NNP	B-NP
O	1141	1142	.	.	.	O

B-Cancer	1143	1148	Tumor	Tumor	NN	B-NP
O	1148	1149	-	-	HYPH	I-NP
O	1149	1157	specific	specific	JJ	I-NP
O	1158	1161	DNA	DNA	NN	I-NP
O	1162	1169	changes	change	NNS	I-NP
O	1170	1174	were	be	VBD	B-VP
O	1175	1183	detected	detect	VBN	I-VP
O	1184	1186	in	in	IN	B-PP
O	1187	1190	two	two	CD	B-NP
O	1191	1201	additional	additional	JJ	I-NP
B-Cancer	1202	1206	HCCs	HCC	NNS	I-NP
O	1206	1207	,	,	,	O
O	1208	1218	suggesting	suggest	VBG	B-VP
O	1219	1223	that	that	IN	B-SBAR
O	1224	1227	the	the	DT	B-NP
O	1228	1233	small	small	JJ	I-NP
O	1234	1240	region	region	NN	I-NP
O	1241	1243	of	of	IN	B-PP
B-Cellular_component	1244	1254	chromosome	chromosome	NN	B-NP
I-Cellular_component	1255	1258	17p	17p	NN	I-NP
O	1259	1266	defined	define	VBN	B-VP
O	1267	1269	by	by	IN	B-PP
O	1270	1273	the	the	DT	B-NP
O	1274	1282	flanking	flanking	NN	I-NP
B-Cell	1283	1287	cell	cell	NN	I-NP
O	1288	1291	DNA	DNA	NN	I-NP
O	1292	1297	probe	probe	NN	I-NP
O	1298	1300	is	be	VBZ	B-VP
O	1301	1309	commonly	commonly	RB	I-VP
O	1310	1317	altered	alter	VBN	I-VP
O	1318	1320	in	in	IN	B-PP
B-Cancer	1321	1330	hepatomas	hepatoma	NNS	B-NP
O	1330	1331	.	.	.	O

O	1332	1343	Restriction	Restriction	NN	B-NP
O	1344	1352	fragment	fragment	NN	I-NP
O	1353	1359	length	length	NN	I-NP
O	1360	1372	polymorphism	polymorphism	NN	I-NP
O	1373	1380	studies	study	NNS	I-NP
O	1381	1393	demonstrated	demonstrate	VBD	B-VP
O	1394	1398	that	that	IN	B-SBAR
O	1399	1402	the	the	DT	B-NP
O	1403	1407	loss	loss	NN	I-NP
O	1408	1410	of	of	IN	B-PP
O	1411	1414	one	one	CD	B-NP
O	1415	1419	copy	copy	NN	I-NP
O	1420	1422	of	of	IN	B-PP
O	1423	1431	portions	portion	NNS	B-NP
O	1432	1434	of	of	IN	B-PP
B-Cellular_component	1435	1445	chromosome	chromosome	NN	B-NP
I-Cellular_component	1446	1448	17	17	CD	I-NP
O	1449	1457	occurred	occur	VBD	B-VP
O	1458	1460	in	in	IN	B-PP
O	1461	1463	10	10	CD	B-NP
O	1464	1465	(	(	(	O
O	1465	1467	53	53	CD	B-NP
O	1467	1468	%	%	NN	I-NP
O	1468	1469	)	)	)	O
O	1470	1472	of	of	IN	B-PP
O	1473	1476	the	the	DT	B-NP
O	1477	1479	19	19	CD	I-NP
O	1480	1488	patients	patient	NNS	I-NP
O	1488	1489	.	.	.	O

O	1490	1493	The	The	DT	B-NP
O	1494	1498	loss	loss	NN	I-NP
O	1499	1501	of	of	IN	B-PP
O	1502	1505	one	one	CD	B-NP
O	1506	1512	allele	allele	NN	I-NP
O	1513	1515	of	of	IN	B-PP
O	1516	1519	the	the	DT	B-NP
O	1520	1523	p53	p53	NN	I-NP
O	1524	1528	gene	gene	NN	I-NP
O	1529	1530	(	(	(	O
O	1530	1537	located	located	JJ	B-ADJP
O	1538	1540	on	on	IN	B-PP
B-Cellular_component	1541	1551	chromosome	chromosome	NN	B-NP
I-Cellular_component	1552	1557	17p13	17p13	NN	I-NP
O	1557	1558	)	)	)	O
O	1559	1567	occurred	occur	VBD	B-VP
O	1568	1570	in	in	IN	B-PP
O	1571	1573	at	at	IN	B-NP
O	1574	1579	least	least	JJS	I-NP
O	1580	1581	6	6	CD	I-NP
O	1582	1583	(	(	(	O
O	1583	1585	60	60	CD	B-NP
O	1585	1586	%	%	NN	I-NP
O	1586	1587	)	)	)	O
O	1588	1590	of	of	IN	B-PP
O	1591	1594	the	the	DT	B-NP
O	1595	1597	10	10	CD	I-NP
O	1598	1606	patients	patient	NNS	I-NP
O	1607	1610	who	who	WP	B-NP
O	1611	1615	were	be	VBD	B-VP
O	1616	1628	heterozygous	heterozygous	JJ	B-ADJP
O	1629	1631	at	at	IN	B-PP
O	1632	1635	the	the	DT	B-NP
O	1636	1639	p53	p53	NN	I-NP
O	1640	1645	locus	locus	NN	I-NP
O	1645	1646	.	.	.	O

O	1647	1649	As	As	IN	B-SBAR
O	1650	1653	the	the	DT	B-NP
O	1654	1657	p53	p53	NN	I-NP
O	1658	1662	gene	gene	NN	I-NP
O	1663	1665	is	be	VBZ	B-VP
O	1666	1671	known	know	VBN	I-VP
O	1672	1674	to	to	TO	I-VP
O	1675	1682	possess	possess	VB	I-VP
B-Cancer	1683	1688	tumor	tumor	NN	B-NP
O	1689	1699	suppressor	suppressor	NN	I-NP
O	1700	1708	activity	activity	NN	I-NP
O	1708	1709	,	,	,	O
O	1710	1713	the	the	DT	B-NP
O	1714	1724	functional	functional	JJ	I-NP
O	1725	1729	loss	loss	NN	I-NP
O	1730	1732	of	of	IN	B-PP
O	1733	1737	this	this	DT	B-NP
O	1738	1742	gene	gene	NN	I-NP
O	1743	1746	may	may	MD	B-VP
O	1747	1749	be	be	VB	I-VP
O	1750	1751	a	a	DT	B-NP
O	1752	1763	significant	significant	JJ	I-NP
O	1764	1768	step	step	NN	I-NP
O	1769	1771	in	in	IN	B-PP
O	1772	1775	the	the	DT	B-NP
O	1776	1787	development	development	NN	I-NP
O	1788	1790	of	of	IN	B-PP
O	1791	1792	a	a	DT	B-NP
O	1793	1799	subset	subset	NN	I-NP
O	1800	1802	of	of	IN	B-PP
B-Cancer	1803	1807	HCCs	HCC	NNS	B-NP
O	1807	1808	.	.	.	O

O	1809	1813	High	High	JJ	B-NP
O	1814	1820	levels	level	NNS	I-NP
O	1821	1823	of	of	IN	B-PP
O	1824	1830	allele	allele	NN	B-NP
O	1831	1835	loss	loss	NN	I-NP
O	1836	1840	also	also	RB	B-ADVP
O	1841	1845	were	be	VBD	B-VP
O	1846	1854	detected	detect	VBN	I-VP
O	1855	1858	for	for	IN	B-PP
B-Cellular_component	1859	1870	chromosomes	chromosome	NNS	B-NP
I-Cellular_component	1871	1873	8q	8q	NN	I-NP
O	1874	1875	(	(	(	O
O	1875	1876	4	4	CD	B-NP
O	1877	1879	of	of	IN	B-PP
O	1880	1881	9	9	CD	B-NP
O	1881	1882	;	;	:	O
O	1883	1885	44	44	CD	B-NP
O	1885	1886	%	%	NN	I-NP
O	1886	1887	)	)	)	O
O	1888	1891	and	and	CC	O
B-Cellular_component	1892	1895	16p	16p	NN	B-NP
O	1896	1897	(	(	(	O
O	1897	1898	5	5	CD	B-NP
O	1899	1901	of	of	IN	B-PP
O	1902	1903	6	6	CD	B-NP
O	1903	1904	;	;	:	O
O	1905	1907	83	83	CD	B-NP
O	1907	1908	%	%	NN	I-NP
O	1908	1909	)	)	)	O
O	1910	1913	and	and	CC	O
O	1914	1917	may	may	MD	B-VP
O	1918	1926	indicate	indicate	VB	I-VP
O	1927	1930	the	the	DT	B-NP
O	1931	1939	presence	presence	NN	I-NP
O	1940	1942	of	of	IN	B-PP
O	1943	1953	additional	additional	JJ	B-NP
B-Cell	1954	1962	cellular	cellular	JJ	I-NP
O	1963	1968	genes	gene	NNS	I-NP
O	1969	1974	whose	whose	WP$	B-NP
O	1975	1985	functional	functional	JJ	I-NP
O	1986	1990	loss	loss	NN	I-NP
O	1991	1993	is	be	VBZ	B-VP
O	1994	2003	important	important	JJ	B-ADJP
O	2004	2006	in	in	IN	B-PP
O	2007	2010	the	the	DT	B-NP
O	2011	2022	development	development	NN	I-NP
O	2023	2025	of	of	IN	B-PP
B-Cancer	2026	2030	HCCs	HCC	NNS	B-NP
O	2030	2031	.	.	.	O

